Create issue ticket

5,456 Possible Causes for 90, Antibody, Humanized, LL2, Monoclonal, Y, Yttrium

Show results in: 日本語

  • Adult T-Cell Leukemia - Lymphoma

    Gov't MeSH terms Adult Antibodies, Monoclonal/immunology* Antibodies, Monoclonal/pharmacology Antigens, CD/genetics Antigens, CD/immunology* Cell Line, Tumor Cell Proliferation[ncbi.nlm.nih.gov] […] and IKKβ, ii) degradation and phosphorylation of IκBα, iii) JunB and JunD, iv) total and phospho-protein levels of Akt, v) phosphorylation of RelA, vi) heat shock protein 90[ncbi.nlm.nih.gov] , Monoclonal, Humanized/adverse effects* Bronchiolitis/chemically induced* Female Haemophilus Infections/chemically induced* Humans Hypoxia Leukemia-Lymphoma, Adult T-Cell[ncbi.nlm.nih.gov] 13 , Torimoto Y 14 , Sato K 15 , Iwasaki H 16 , Haseyama Y 17 , Kohda K 18 , Nagamachi Y 19 , Hirayama Y 20 , Sakai H 21 , Hirata Y 22 , Fukuhara T 23 , Ikeda H 2 , Kobune[ncbi.nlm.nih.gov] Yttrium Y 90-ibritumomab tiuxetan is an example of a radiolabeled monoclonal antibody. Monoclonal antibodies are given by infusion.[northshore.org] More patients were aged 90 years (2.6 %), in this study, than in a nationwide survey ( KEYWORDS: Adult T-cell leukemia–lymphoma; Okinawa; Retrospective analysis; Strongyloidiasis[ncbi.nlm.nih.gov] Int J Hematol. 2009 Oct;90(3):397-401. doi: 10.1007/s12185-009-0406-2. Epub 2009 Aug 25.[ncbi.nlm.nih.gov]

    Missing: LL2
  • Influenza

    Antibodies are therefore considered to play an important role in preventing infectious diseases.[doi.org] 7 0–90 0.76 0.41, 1.40 12 Pneumococcal vaccination 0–90 0.61 0.08, 4.42 1 Influenzalike illness 0–30 16.64 9.37, 29.54 15 31–60 4.70 1.70, 13.0 4 61–90 0 0 0–90 7.35 4.36[doi.org] The rapid evolution of influenza A and B viruses contributes to annual influenza epidemics in humans.[ncbi.nlm.nih.gov] Y , Osaki S , Ryuto M , Sakaguchi S , Sakayori S , Sasaki Y , Sato S , Sato T , Sato Y , Sato Y , Segawa Y , Shibasaki A , Shimamoto E , Shimomura H , Sugiura T , Suzuki[ncbi.nlm.nih.gov] Our patient responded to the combination of intravenous immunoglobulin, prednisone, and anti-CD20 monoclonal antibody, rituximab.[ncbi.nlm.nih.gov] Here, we report the isolation and characterization of a human monoclonal antibody CR8020 with broad neutralizing activity against most group 2 viruses, including H3N2 and[doi.org] Influenza A virus M2 protein: monoclonal antibody restriction of virus growth and detection of M2 in virions. J. Virol. 62 , 2762–2772 (1988). 6.[doi.org]

    Missing: LL2 Yttrium
  • Daclizumab

    Gov't MeSH terms Antibodies, Monoclonal/chemistry* Antibodies, Monoclonal/therapeutic use Antibodies, Monoclonal, Humanized Basiliximab Binding Sites Complementarity Determining[ncbi.nlm.nih.gov] Forty-six patients with refractory and relapsed HL were evaluated with up to seven i.v. infusions of the radiolabeled anti-CD25 antibody (90)Y-daclizumab. (90)Y provides strong[ncbi.nlm.nih.gov] To date, nine humanized monoclonal antibodies have been approved for use as human therapeutics in the United States.[ncbi.nlm.nih.gov] […] [email protected] Abstract Following the recent approval of the first oral therapy for multiple sclerosis (MS), fingolimod, multiple other oral compounds, and also a number of monoclonal[ncbi.nlm.nih.gov] One fusion antibody links the antibody with radioactive yttrium (Y 90), effectively bringing radiation therapy directly to the cancer cells.[encyclopedia.com] The geometric mean ratio for urine dextromethorphan to dextrorphan ratio was 1.01, with the 90% CI (0.76-1.34) extending slightly outside the no-effect boundary, likely due[ncbi.nlm.nih.gov] Author information 1 Unidad de Insuficiencia Cardiaca y Trasplante, Servicio de Cardiología, Hospital Universitario La Fe, Valencia, España.[ncbi.nlm.nih.gov]

    Missing: LL2
  • Infectious Mononucleosis

    Although the warm autoantibody disappeared after 2 months, the antiphospholipid antibodies remained persistently positive.[ncbi.nlm.nih.gov] The only sex-related factor is the complication of splenic rupture; more than 90% of these cases occur in males.[emedicine.medscape.com] Author information 1 Michigan State University College of Human Medicine, East Lansing, MI, United States. 2 Section of Emergency Medicine, Department of Internal Medicine[ncbi.nlm.nih.gov] Yokoyama T 1 , Tokuhisa Y , Toga A , Fujiki T , Sakakibara Y , Mase S , Araki R , Nishimura R , Wada T , Fuseda T , Kato E , Yachie A .[ncbi.nlm.nih.gov] Monoclonal proliferation of EBV-infected cells was detected in the PBMCs by Southern blotting for EBV-terminal repeat (EBV-TR).[ncbi.nlm.nih.gov] The proportion of EBV-related HL increased with age from 23% in the age group of 15 to 34 y to 28% in the age group of 35 to 49 y and 43% in the age group of 50 to 80 y ([dx.doi.org] Posttransplant lymphoproliferative disorder (PTLD) is a potentially fatal lymphoproliferative syndrome associated with Epstein-Barr virus and monoclonal or polyclonal expansion[emedicine.com]

    Missing: LL2 Yttrium
  • Iodine-131-Tositumomab

    Abstract Iodine-131 tositumomab [B1, Bexxar , iodine-131 anti-B1 antibody] is a murine antibody conjugated to iodine 131 that recognises and binds to the B1 (CD20) antigen[ncbi.nlm.nih.gov] Of 90 eligible patients, 86 completed CHOP and 77 both phases.[nature.com] DESCRIPTION CATALOG # SIZE PRICE Anti-Human CD20 Stable Cell Line (Bexxar) CSC-P0113 1 10 7 cells/vial Please Inquiry Product Detail Cat CSC-P0113 Trade name bexxar CAS 192391[creative-biolabs.com] MeSH terms Adult Antibodies, Monoclonal/adverse effects Antibodies, Monoclonal/pharmacokinetics Antibodies, Monoclonal/therapeutic use* Antineoplastic Combined Chemotherapy[ncbi.nlm.nih.gov] It is the second radioimmunoconjugate to be approved for refractory NHL; yttrium-90 linked to ibritumomab tiuxetan (Zevalin) was approved in 2002.[secure.medicalletter.org] Tositumomab is an immunoglobulin G murine monoclonal antibody that binds to the CD20 antigen on the surface of normal and malignant human B-cells.[ncbi.nlm.nih.gov] Large B-Cell Lymphoma (DLBCL) The results from this Phase II study from SWOG are in contrast to a study at Memorial Sloan-Kettering, where we administered R-CHOP followed by yttrium[slideplayer.com]

    Missing: LL2
  • Waldenstrom Macroglobulinemia

    ; and (3) binding of this circulating IgM-kappa antiepidermal basement membrane zone antibody to both sides of 1 mol/L sodium chloride split skin.[ncbi.nlm.nih.gov] For example, a 5-year survival rate of 90% means that an estimated 90 out of 100 people who have that cancer are still alive 5 years after being diagnosed.[cancer.org] , CXCR4 Sulfonamides Protein-Tyrosine Kinases Agammaglobulinaemia Tyrosine Kinase BTK protein, human Proto-Oncogene Proteins c-akt venetoclax Grant support N01 CA015083/CA[ncbi.nlm.nih.gov] Hunter ZR, Xu L, Yang G, Zhou Y, Liu X, Cao Y, Manning RJ, Tripsas C, Patterson CJ, Sheehy P, Treon SP.[ghr.nlm.nih.gov] IgM monoclonal gammopathy of undetermined significance (IgM MGUS) and Waldenström macroglobulinemia (WM) are sometimes clinically difficult to distinguish.[ncbi.nlm.nih.gov] . : Randomized controlled trial of yttrium-90-labeled ibritumomab tiuxetan radioimmunotherapy versus rituximab immunotherapy for patients with relapsed or refractory lowgrade[doi.org] Two monoclonal Igs (whole IgG1/kappa and IgG1/kappa half molecules) occurred in the serum in addition to the IgM monoclonal protein.[ncbi.nlm.nih.gov]

    Missing: LL2
  • Trastuzumab

    In vivo, trastuzumab inhibits angiogenesis and induces antibody-dependent cellular cytotoxicity.[ncbi.nlm.nih.gov] : RR 1.83; 90% CI 1.36 to 2.47, P 0.0008).[doi.org] Details Trastuzumab is a recombinant humanized monoclonal immunoglobulin G1 kappa antibody that binds with high affinity and specificity to the extracellular domain of the[biovision.com] Kimura Y 1 , Fujii M 2 , Masuishi T 3 , Nishikawa K 4 , Kunisaki C 5 , Matsusaka S 6 , Segawa Y 7 , Nakamura M 8 , Sasaki K 9 , Nagao N 10 , Hatachi Y 11 , Yuasa Y 12 , Asami[ncbi.nlm.nih.gov] PURPOSE: The aim of this study was to determine if imaging with Zr-trastuzumab, a human epidermal growth factor receptor 2 (HER2)-targeting PET tracer, can detect HER2-positive[ncbi.nlm.nih.gov] A subclass of tumor-inhibitory monoclonal antibodies to ErbB-2/HER2 blocks crosstalk with growth factor receptors. Oncogene 1997; 14:2099–2109.[doi.org] Here we utilized human induced pluripotent stem cell-derived cardiomyocytes (iPS-CMs) to model trastuzumab-related cardiotoxicity in vitro.[ncbi.nlm.nih.gov]

    Missing: LL2 Yttrium
  • Acquired Hemophilia A

    Conclusion Although the Nijmegen-modified Bethesda assay is the reference standard for demonstrating neutralizing antibodies, the detection of FVIII-binding antibodies by[ncbi.nlm.nih.gov] Therapy with Yttrium-90 Resin Microspheres [SIRTex]).[ncbi.nlm.nih.gov] The patient was successfully treated with activated recombinant human factor VII (rhFVIIa) and immunosuppression.[ncbi.nlm.nih.gov] Nishida S 1 , Kawasaki T , Kashiwagi H , Morishima A , Hishitani Y , Kawai M , Hirano T , Ishii T , Hagihara K , Shima Y , Narazaki M , Ogata A , Oka Y , Kishimoto T , Tanaka[ncbi.nlm.nih.gov] At last, she was successfully treated through the use of an anti-CD20 monoclonal antibody.[ncbi.nlm.nih.gov] Prior to surgery, he required 100% plasma exchange with human plasma derived prothrombin complex concentrate (Octaplex) as the exchange fluid.[ncbi.nlm.nih.gov] , Ogawa Y 1, 4 .[ncbi.nlm.nih.gov]

    Missing: LL2
  • Follicular Lymphoma

    The antibody is trademarked Rituxan in the U.S., Japan, and Canada.[genengnews.com] PURPOSE: We conducted an international, randomized, phase III trial to evaluate the efficacy and safety of consolidation with yttrium-90 ((90)Y)-ibritumomab tiuxetan in patients[ncbi.nlm.nih.gov] Abstract: After twenty years of use in humans, customized idiotypic vaccination yet remains a non-approved, experimental therapeutic option for patients with lymphoma and[doi.org] , Yamasaki R 1 , Kawasaki Y 1 , Sugimoto M 1 , Ashizawa M 1 , Yamamoto C 1 , Hatano K 1 , Sato K 1 , Oh I 1 , Ohmine K 1 , Muroi K 1 , Kanda Y 2 .[ncbi.nlm.nih.gov] Compared to previous reports, we used a more sensitive FCI method by combining both monoclonal and polyclonal anti-LC antibodies.[ncbi.nlm.nih.gov] Abstract Yttrium 90 ((90)Y) ibritumomab tiuxetan (Zevalin), a radiolabeled monoclonal antibody against the CD20 antigen, is indicated for the treatment of patients with relapsed[ncbi.nlm.nih.gov] Positron Emission Tomography Computed Tomography/methods Prednisone/therapeutic use Tomography, X-Ray Computed/methods Vincristine/therapeutic use Substances Antibodies, Monoclonal[ncbi.nlm.nih.gov]

    Missing: LL2
  • Acquired Hemophilia

    Conclusion Although the Nijmegen-modified Bethesda assay is the reference standard for demonstrating neutralizing antibodies, the detection of FVIII-binding antibodies by[ncbi.nlm.nih.gov] Therapy with Yttrium-90 Resin Microspheres [SIRTex]).[ncbi.nlm.nih.gov] […] dedicated to delivering transformative therapies to patients with orphan diseases and underserved conditions, today announced that the Committee for Medicinal Products for Human[businesswire.com] Nishida S 1 , Kawasaki T , Kashiwagi H , Morishima A , Hishitani Y , Kawai M , Hirano T , Ishii T , Hagihara K , Shima Y , Narazaki M , Ogata A , Oka Y , Kishimoto T , Tanaka[ncbi.nlm.nih.gov] The hemophilia followed a relapsing course under oral corticosteroid therapy, but B-cell depletion with anti-CD20 monoclonal antibody (rituximab) was effective in inducing[ncbi.nlm.nih.gov] We report on a 92-year-old male, administered two courses of 90 microg kg(-1) of recombinant activated factor VII (rFVIIa) due to failure of human factor VIII (FVIII) therapy[ncbi.nlm.nih.gov] , Ogawa Y 1, 4 .[ncbi.nlm.nih.gov]

    Missing: LL2